Precision Biosciences (DTIL) EBT Margin Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | 7.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.33 Mn |
| Dec 31, 2025 | 377,448.00 |
| Sep 30, 2025 | -20.75 Mn |
| Jun 30, 2025 | -12.32 Mn |
| Mar 31, 2025 | -7.33 Mn |
| Dec 31, 2024 | -354,214.00 |
| Sep 30, 2024 | -503,304.00 |
| Jun 30, 2024 | 6,951.00 |
| Mar 31, 2024 | 11,772.00 |
| Dec 31, 2023 | -8,275.00 |
| Sep 30, 2023 | 10,835.00 |
| Jun 30, 2023 | 90,051.00 |
| Mar 31, 2023 | 89,658.00 |
| Dec 31, 2022 | 37,184.00 |
| Sep 30, 2022 | -9,855.00 |
| Jun 30, 2022 | -96,723.00 |
| Mar 31, 2022 | -91,355.00 |
| Dec 31, 2021 | -21,060.00 |
| Sep 30, 2021 | 29,998.00 |
| Jun 30, 2021 | 328,509.00 |